Related Experiment Video
Updated: Mar 9, 2026
11:38
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
47.6K
Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized
Leen Paelinck1, Akos Gulyban2, Ferenc Lakosi2
1Dept. of Radiation Oncology, Ghent University Hospital, Belgium.
Summary
This study compared simultaneous integrated boost (SIB) with sequential boost (SeB) for hypofractionated whole-breast irradiation (WBI). While moist desquamation rates were similar, SIB showed reduced dermatitis and pruritus, suggesting improved safety.
Area of Science:
- Oncology
- Radiation Oncology
- Clinical Trials
Background:
- Hypofractionated whole-breast irradiation (WBI) is an evolving treatment modality.
- Assessing the safety of simultaneous integrated boost (SIB) techniques is crucial for optimizing radiation therapy protocols.
Purpose of the Study:
- To investigate the safety and efficacy of simultaneous integrated boost (SIB) compared to sequential boost (SeB) in prone hypofractionated whole-breast irradiation.
- To evaluate acute toxicity profiles, including dermatitis and pruritus, between the two irradiation techniques.
Main Methods:
- A randomized trial involving 167 patients comparing WBI with SeB versus SIB.
- All patients received 40.05Gy in 15 fractions, with SIB delivering higher doses to boost regions based on margin status.
- Data on moist desquamation, dermatitis, pruritus, and edema were collected and analyzed.
Main Results:
- The primary endpoint, moist desquamation, showed no significant difference between SIB and SeB arms (6/83 in both).
- Grade 2/3 dermatitis was significantly more frequent in the SeB arm (38/83 vs. 24/83, p=0.037).
- Pruritus occurred less frequently in the SIB arm (43% vs. 61%, p=0.015).
Conclusions:
- Simultaneous integrated boost (SIB) is a safe and potentially better-tolerated alternative to sequential boost (SeB) in hypofractionated WBI.
- SIB demonstrated a reduced incidence of grade 2/3 dermatitis and pruritus compared to SeB.
- Further research may support SIB as a preferred method for delivering boost doses in WBI.
Related Concept Videos
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
196
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
196
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
511
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
511